Matching clinical and biological specificity: implications for biological psychiatry.
作者信息
Pivik R T
出版信息
J Psychiatry Neurosci. 1992 Oct;17(4):132.
Abstract
摘要
相似文献
1
Matching clinical and biological specificity: implications for biological psychiatry.匹配临床与生物学特异性：对生物精神病学的启示
J Psychiatry Neurosci. 1992 Oct;17(4):132.
2
Dopamine receptor genes: new tools for molecular psychiatry.多巴胺受体基因：分子精神病学的新工具。
J Psychiatry Neurosci. 1992 Oct;17(4):158-80.
3
Schizophrenia: D4 receptor elevation. What does it mean?精神分裂症：D4受体升高。这意味着什么？
J Psychiatry Neurosci. 1994 May;19(3):171-6.
4
Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems.多巴胺D1、D2、D3和D4受体基因与多种诊断系统所定义的精神分裂症之间的关联研究。
Biol Psychiatry. 1996 Sep 1;40(5):419-21. doi: 10.1016/0006-3223(95)00425-4.
5
[Molecular genetics of cognitive deficit in schizophrenia].[精神分裂症认知缺陷的分子遗传学]
Mol Biol (Mosk). 2008 Sep-Oct;42(5):830-9.
6
Schizophrenia and DA-hypothesis: pathological and therapeutic aspects. 9th annual meeting of the Belgian College of Neuropsychopharmacological and Biological Psychiatry. Louvain-en-Woluwe, 21 November 1986. Proceedings.精神分裂症与多巴胺假说：病理及治疗方面。比利时神经精神药理学与生物精神病学学院第九次年会。于伊夫林堡，1986年11月21日。会议论文集
Acta Psychiatr Belg. 1987 Sep-Oct;87(5):521-617.
7
Role of glucocorticoids in dopamine-related neuropsychiatric disorders.糖皮质激素在多巴胺相关神经精神疾病中的作用。
Mol Cell Endocrinol. 2005 Dec 21;245(1-2):10-22. doi: 10.1016/j.mce.2005.10.007. Epub 2005 Nov 28.
8
Pharmacotherapy of schizophrenia: a review.精神分裂症的药物治疗：综述
Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S70-5.
9
Dopamine receptors and the dopamine hypothesis of schizophrenia.多巴胺受体与精神分裂症的多巴胺假说
Synapse. 1987;1(2):133-52. doi: 10.1002/syn.890010203.
10
[Neuroendocrinology and schizophrenia research].
Monogr Gesamtgeb Psychiatr Psychiatry Ser. 1991;64:1-96.
Zotero 插件